DARATUMUMAB
| Source | Section 100 (CT) |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES |
|
|
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 12682LMP | DARATUMUMAB daratumumab 1.8 g/15 mL injection, 15 mL vial (PI, CMI) |
1 | 1 | 5 | $7010.28 | $31.60 | $31.60 |
| Available brands | |||||||
| Darzalex SC |
- Legend
- MPMedical Practitioner




